-
2010
8. juni 2010:Pressemeddelelse nr. 5, 2010: Zealand Pharma Announces An Extension of The Lixisenatide...
-
Meet us
The 31st European Peptide Symposium, Copenhagen, Denmark, 5-9 September 2010 (Science) 46th An...
2010
Werner, U., Haschke, H., Herling, A.W., Kramer, W.:
Pharmacological profile of lixisenatide: A new GLP-1 receptor agonist for the treatment of type 2 diabetes.
Regulatory Peptides 2010, 164, 58–64
Daugaard, J.R., Meier, E., Riber, D., Bæk, C.Æ., Larsen, K., Kampen, G.:
The New Dual Glucagon-GLP-1 Agonist ZP2929 Improves Glycemic Control and Reduces Body Weight in Murine Models of Obesity and insulin Type 2 Diabetes.
The American Diabetes Association’s (ADA) 70th Scientific Sessions, 25-29 June, 2010, Orlando, FL, USA
Diabetes, 2010, 59, Suppl 1,1630-P, p A430
Poster
Axelsen, L.N., Pedersen, H.D., Petersen, J.S., Holstein-Rathlou, N-H. and Kjølbye, A.L.
Metabolic and cardiac changes in high cholesterol–fructose-fed rats
J Pharmacol.Toxicol.Methods, 2010, 61, 292-296
Axelsen, L.N., Lademann, J.B., Petersen, J.S., Holstein-Rathlou, N.-H., Ploug, T. Prats,C., Pedersen, H.D., and Kjølbye, A.L.
Cardiac and metabolic changes in long-term high fructose-fat fed rats with severe obesity and extensive intramyocardial lipid accumulation.
Am.J Physiol Regul.Integr.Comp Physiol, 2010, 298, R1560-R1570
Knudsen, C.B. and Jensen, A.L.
Simultaneous Quantitative Determination of ZP1848 and Two Metabolites in Human Plasma Using Immunoaffinity-Precipitation LC/MS/MS
“2010 AAPS National Biotechnology Conference” in San Francisco, CA, USA, May 16-19 2010
Poster
Solomon, D.H.
Turning Peptides into Drug
“PepCon-2010” in Beijing, Kina, March 21-23 2010
Oral presentation
Larsen, B.D., Verma, V. Coombs, W., Lin, X., Spagnol, G., Sorgen, P.L., Taffet, S., and Delmar, M.
Discovery of novel small peptidomimetics that prevent cardiac gap junction closure and action potential propagation block. - From a 34 amino acid peptide RXP-E to active 3 amino acid peptide mimetics
“PepCon-2010” in Beijing, Kina, March 21-23 2010
Abstract
Oral presentation
Delmar, M, Lewandowski, R., Procida, K., Vaidyanathan, R., Coombs, W., Jalife, J., Nielsen, M.S., Larsen, B.D., Taffet, S.M.
RXP-E: A Cx43-binding peptide that prevents action potential propagation block
“PepCon-2010” in Beijing, Kina, March 21-23 2010
Abstract
Oral presentation
Ellegaard, M., Thorkildsen, C., Petersen, S., Petersen, J.S., Jørgensen, N.R., Just, R., Schwarz, P., Ramirez, M.T., Stahlhut, M.
Amylin(1-8) is Devoid of Anabolic Activity in Bone
Calcif.Tissue Int., 2010, 249-260
Tip a friend
Fill in the form below to tip a friend about this page.
Subscribe
When this page is updated you will be updated by e-mail.
Home Legal Disclaimer Updated: 1.9.2010